Awiqli is the world's first once-a-week basal insulin injection ...

Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

India has become one of the first countries to introduce Awiqli, the world’s first once-weekly basal insulin for adults with ...

Designed to reduce daily insulin injections to a single weekly dose, the long-acting insulin aims to improve treatment ...

Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

India: Awiqli (insulin icodec), a once-weekly basal insulin injection for adults with type 1 and type 2 diabetes, has been ...

Danish pharmaceutical giant Novo Nordisk, on June 9, launched Awiqli, its once-weekly basal insulin injection | One of ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

In a major healthcare development, India has become one of the first countries in the world to introduce basal insulin that ...

Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.